The reform of the Handbook for "therapeutically similar" categories starts today negotiated by Aifa in September with the manufacturing companies. Yesterday, in fact, the Agency published on its website the Transparency List of generic drugs with the new reimbursement levels and prices to the public resulting from the operation. As the accompanying text explains [ed: see below], the prices come into force as of today while the reimbursement quotas are triggered only in the Regions that have adopted the automatic adjustment to the Aifa lists. In the others however, it will depend on the date of publication of the implementing resolutions.
The list - which reduces the prices of 265 packs - should be followed by another listregarding the branded drugs involved in the review. In fact, as required by law 125/2015 (local authority decree), AIFA conducted the negotiation by keeping on and off patent medicines separate. (AS)
_______________________________________________________
AIFA. Transparency Lists - Annex B Resolution 1267/2015 (updated 09/30/2015)
The Italian Medicines Agency publishes Annex B of Resolution 1267/2015 (Renegotiation of the price of medicines paid by the NHS within groupings of therapeutically similar medicines) containing the complete list of medicines authorized and regularly on the market at the date of 30 September 2015 drawn up pursuant to article 7, paragraph 1, of the decree law n.347/2001, converted into law n. 405/2001 and subsequent amendments and the related reference prices net of the reductions established with the AIFA Resolution of 8 April 2011 issued pursuant to paragraph 9 of article 11 of decree law 78/2010 and the further price reductions resulting from the negotiation pursuant to article 11, paragraph 1, of the decree law of 13 September 2012, n.158, converted, with amendments, by the law of 8 November 2012, n.189.
The prices to the public of the medicinal products listed are indicated net of the legal reductions pursuant to the AIFA Resolution of 30 December 2005, the AIFA Resolution of 3 July 2006, the further reduction of 5% pursuant to the AIFA Resolution of 27 September 2006 and the AIFA Resolution of 1 December 2014.
The list will be effective from the day following its publication on the AIFA Institutional Portal.
Attached:
List of medicines - Annex B Determina 1267/2015 – .pdf format (30/09/2015)
List of medicines - Annex B Determina 1267/2015 – .ods format (09/30/2015)
List of medicines - Annex B Determina 1267/2015 – .csv format (30/09/2015) (released under license CC-BY – Limits on the reuse of personal data)
Related news: Assogenerici: "With new reference prices, the production of equivalents becomes unsustainable"
